{"nctId":"NCT00560417","briefTitle":"Comparison of Two Basal Insulins for Patients With Type 2 Diabetes Taking Oral Diabetes Medicines and Exenatide","startDateStruct":{"date":"2007-11"},"conditions":["Diabetes Mellitus, Type 2"],"count":339,"armGroups":[{"label":"ILPS","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Insulin Lispro Protamine Suspension"]},{"label":"Glargine","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Insulin Glargine"]}],"interventions":[{"name":"Insulin Lispro Protamine Suspension","otherNames":["LY275585[P]"]},{"name":"Insulin Glargine","otherNames":["Lantus"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Must have type 2 diabetes\n* Must be at least 18 years of age and less than 75 years of age\n* Must be taking exenatide 10 micrograms twice a day (BID) for at least 3 months\n* Must be taking one of the following oral diabetes medication regimens for at least 3 months: (1) metformin (2) metformin + sulfonylurea (3) metformin + thiazolidinedione (TZD). Doses must be at or above the following: Metformin--1500 mg/day, Sulfonylurea--1/2 the maximum daily dose according to the product label, TZD--30 mg/day pioglitazone\n* Must have a hemoglobin A1C greater than or equal to 7.0% and less than or equal to 10.0%\n\nExclusion Criteria:\n\n* Must not have used insulin on a regular basis during the past 2 years\n* Must not have taken any glucose-lowering medications not included in the inclusion criteria in the past 3 months\n* Must not have had more than one episode of severe hypoglycemia in the past 6 months\n* Must not have clinically significant hematologic, oncologic, renal, cardiac, hepatic, or gastrointestinal disease\n* Must not be pregnant or intend to get pregnant during the course of the study","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","maximumAge":"74 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Change From Baseline in Hemoglobin A1C (HbA1c) at Endpoint (Last Observation Carried Forward [LOCF])","description":"Least squares mean values were controlled for Baseline + Baseline HbA1c Group + Baseline sulfonylurea (SU) Group.","paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"8.48","spread":"0.04"},{"groupId":"OG001","value":"8.47","spread":"0.04"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.21","spread":"0.07"},{"groupId":"OG001","value":"-1.43","spread":"0.07"}]}]}]},{"type":"SECONDARY","title":"Actual Hemoglobin A1C at 24 Weeks and Endpoint (LOCF)","description":"Least squares mean values were controlled for Baseline + Baseline HbA1c Group + Baseline SU Group.","paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"6.94","spread":"0.07"},{"groupId":"OG001","value":"6.70","spread":"0.06"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"7.00","spread":"0.07"},{"groupId":"OG001","value":"6.78","spread":"0.07"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Hemoglobin A1C at 24 Weeks and Endpoint (LOCF)","description":"Least squares mean values were controlled for Baseline + Baseline HbA1c Group + Baseline SU Group.","paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"8.48","spread":"0.04"},{"groupId":"OG001","value":"8.47","spread":"0.04"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.25","spread":"0.07"},{"groupId":"OG001","value":"-1.49","spread":"0.06"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.21","spread":"0.07"},{"groupId":"OG001","value":"-1.43","spread":"0.07"}]}]}]},{"type":"SECONDARY","title":"Percentage of Participants With Hemoglobin A1C Less Than 7.0% and Hemoglobin A1C Less Than or Equal to 6.5%","description":null,"paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"46.9","spread":null},{"groupId":"OG001","value":"50.7","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"24.8","spread":null},{"groupId":"OG001","value":"28.7","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"54.8","spread":null},{"groupId":"OG001","value":"69.1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"30.8","spread":null},{"groupId":"OG001","value":"37.6","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"55.4","spread":null},{"groupId":"OG001","value":"63.4","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"29.7","spread":null},{"groupId":"OG001","value":"39.9","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"53.7","spread":null},{"groupId":"OG001","value":"61.7","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"28.4","spread":null},{"groupId":"OG001","value":"38.9","spread":null}]}]}]},{"type":"SECONDARY","title":"7-Point Self-Monitored Blood Glucose (SMBG) Profiles at Baseline and Endpoint (LOCF)","description":"SMBG at morning pre-meal, morning post-prandial, midday pre-meal, midday post-prandial, evening pre-meal, evening postprandial, 0300 hours. Post-prandial glucose is measured 2 hours after the start of the meal.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"175.41","spread":"39.54"},{"groupId":"OG001","value":"180.86","spread":"38.95"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"195.31","spread":"54.65"},{"groupId":"OG001","value":"190.84","spread":"54.95"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"165.18","spread":"43.51"},{"groupId":"OG001","value":"166.34","spread":"47.64"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"193.22","spread":"46.95"},{"groupId":"OG001","value":"200.25","spread":"54.64"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"173.33","spread":"44.60"},{"groupId":"OG001","value":"175.14","spread":"43.35"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"189.00","spread":"49.62"},{"groupId":"OG001","value":"184.92","spread":"49.42"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"170.51","spread":"43.44"},{"groupId":"OG001","value":"172.00","spread":"39.10"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"180.19","spread":"36.95"},{"groupId":"OG001","value":"180.72","spread":"38.17"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"170.60","spread":"36.06"},{"groupId":"OG001","value":"172.66","spread":"38.60"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"192.37","spread":"41.48"},{"groupId":"OG001","value":"191.27","spread":"46.11"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"129.63","spread":"31.58"},{"groupId":"OG001","value":"127.01","spread":"29.08"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"152.32","spread":"44.81"},{"groupId":"OG001","value":"137.39","spread":"36.65"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"132.84","spread":"36.63"},{"groupId":"OG001","value":"129.71","spread":"34.34"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"161.77","spread":"42.46"},{"groupId":"OG001","value":"155.26","spread":"37.86"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"146.03","spread":"37.93"},{"groupId":"OG001","value":"135.93","spread":"33.79"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"159.14","spread":"45.35"},{"groupId":"OG001","value":"144.25","spread":"34.17"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"123.96","spread":"35.45"},{"groupId":"OG001","value":"127.53","spread":"30.90"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"143.06","spread":"30.00"},{"groupId":"OG001","value":"136.17","spread":"25.65"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"135.51","spread":"30.39"},{"groupId":"OG001","value":"129.32","spread":"26.54"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"158.10","spread":"36.81"},{"groupId":"OG001","value":"146.12","spread":"30.37"}]}]}]},{"type":"SECONDARY","title":"Glycemic Variability at Baseline and Endpoint (LOCF)","description":"Glycemic variability was defined as the standard deviation (SD) of a participant's intra-day 7-point, self-monitored, blood glucose. Mean SD was calculated based on the SD for each participant in the study.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"41.15","spread":"13.69"},{"groupId":"OG001","value":"39.02","spread":"13.52"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"36.78","spread":"16.02"},{"groupId":"OG001","value":"30.96","spread":"13.24"}]}]}]},{"type":"SECONDARY","title":"Incidence of Self-reported Hypoglycemic Episodes (All, Non-Nocturnal, Nocturnal, and Severe)","description":"Overall:any time after randomization.Episode:any time patient experienced sign/symptom associated with hypoglycemia, or had blood glucose level â‰¤70 mg/dL. Non-nocturnal:any episode that occurred between waking and bedtime. Nocturnal:any episode that occurred between bedtime and waking.Severe:episode with symptoms consistent with neuroglycopenia in which patient requires assistance,and is associated with:blood glucose value \\<50 mg/dL or prompt recovery after oral carbohydrate, glucagon, or intravenous glucose.Incidence(%)=(Number of patients experiencing episodes/number of patients in arm)\\*100.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"41.8","spread":null},{"groupId":"OG001","value":"43.1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"70.6","spread":null},{"groupId":"OG001","value":"74.9","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"30.6","spread":null},{"groupId":"OG001","value":"40.1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"62.4","spread":null},{"groupId":"OG001","value":"70.7","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"21.8","spread":null},{"groupId":"OG001","value":"11.4","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"47.6","spread":null},{"groupId":"OG001","value":"37.1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.8","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]}]},{"type":"SECONDARY","title":"Rate of All, Non-Nocturnal, and Nocturnal Self-Reported Hypoglycemic Episodes (Adjusted for One Year)","description":"Rate of self-reported hypoglycemic episodes, all, non-nocturnal, and nocturnal, at Endpoint (LOCF) and overall. Rate is reported as episodes/participant/365 days. Episode = any time participant feels that he/she is experiencing a sign or symptom that is associated with hypoglycemia or has a blood glucose level of â‰¤70 mg/dL, even if it was not associated with signs, symptoms, or treatment. Overall=any time during the post-randomization visits within the study period. Nocturnal=Any episode that occurs between bedtime and waking. Non-Nocturnal=Any episode that occurs between waking and bedtime.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"14.51","spread":"27.75"},{"groupId":"OG001","value":"15.29","spread":"29.73"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"16.27","spread":"23.19"},{"groupId":"OG001","value":"18.05","spread":"24.59"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"10.40","spread":"23.46"},{"groupId":"OG001","value":"13.20","spread":"28.01"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"11.36","spread":"19.16"},{"groupId":"OG001","value":"14.83","spread":"21.00"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.01","spread":"9.73"},{"groupId":"OG001","value":"1.73","spread":"5.53"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.88","spread":"8.43"},{"groupId":"OG001","value":"3.01","spread":"7.21"}]}]}]},{"type":"SECONDARY","title":"Actual Body Weight at Baseline and Endpoint (LOCF)","description":null,"paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"101.57","spread":"18.67"},{"groupId":"OG001","value":"102.62","spread":"19.58"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"101.85","spread":"18.91"},{"groupId":"OG001","value":"103.28","spread":"19.42"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Body Weight at Endpoint (LOCF)","description":null,"paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.27","spread":"3.38"},{"groupId":"OG001","value":"0.66","spread":"3.93"}]}]}]},{"type":"SECONDARY","title":"Total Daily Insulin Dose at Endpoint (LOCF)","description":null,"paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"31.11","spread":"18.87"},{"groupId":"OG001","value":"37.93","spread":"18.46"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":9,"n":170},"commonTop":["Headache","Diarrhoea","Nausea","Nasopharyngitis","Upper respiratory tract infection"]}}}